Genomma Lab Internacional (GNMLF) Expected to Release Earnings on Wednesday

Genomma Lab Internacional (OTCMKTS:GNMLF) is projected to issue its resultson Wednesday, July 22nd. Analysts expect Genomma Lab Internacional to post earnings of $0.0268 per share and revenue of $256.24 million for the quarter.

Genomma Lab Internacional Price Performance

GNMLF stock opened at $0.86 on Monday. Genomma Lab Internacional has a twelve month low of $0.84 and a twelve month high of $1.17. The business’s 50-day simple moving average is $0.96 and its 200 day simple moving average is $1.00.

Analysts Set New Price Targets

Separately, Jefferies Financial Group began coverage on Genomma Lab Internacional in a research report on Sunday. They issued a “hold” rating for the company. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of “Hold”.

About Genomma Lab Internacional

Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.

The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.